Plasma soluble programmed death ligand 1 levels predict clinical response in peripheral T‐cell lymphomas

Xuhan Zhang(Tianjin Medical University Cancer Institute and Hospital), Kai Fu(Tianjin Medical University Cancer Institute and Hospital)
Hematological Oncology
May 10, 2019
10.1002/hon.2636
Cited by 27

Related Papers

Targeting EZH1/2 induces cell cycle arrest and inhibits cell proliferation through reactivation of p57CDKN1C and TP53INP1 in mantle cell lymphoma
|Cancer Biology and Medicine|2019|28
Programmed Cell Death Protein 1/Programmed Cell Death Ligand-1 Axis activates Intracellular ERK Signaling in Tumor Cells to Mediate Poor Prognosis in T-cell Lymphoma
|Journal of Cancer|2021|1